Heavy Burden: Heavy Burden: Multiple Risk Factor Profile In Hypertension Patients Dong Zhao MD, PhD Department of Epidemiology Beijing Institute of Heart,

Slides:



Advertisements
Similar presentations
noncommunicable diseases
Advertisements

Health Statistics and Informatics Global Health Risks: Selected figures and tables Health Statistics and Informatics Department.
Epidemiology of Peripheral Vascular Disease Sohail Ahmed School of Population and Health Sciences.
Bridget Dillon February 11,  Cardiovascular disease affects the heart and circulatory system. It is often a result of blockages of blood vessels.
Burden of Cardiovascular Disease in Mississippi. Top Ten Leading Causes of Death in Mississippi, 2007 Source: Mississippi Vital Statistics, 2007.
Absolute cardiovascular disease risk Assessment and Early Intervention Dr Michael Tam Lecturer in Primary Care
Cholesterol quintile (mg/dL)
Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program Clinical Goals for the Healthy.
Chapter Twelve Importance of Noncommunicable Disease.
The concept of Diabetes & CV risk: A lifetime risk challenge
Lifetime Risk of Coronary Heart Disease in the Framingham Study
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
LIFESTYLE MODIFICATIONS FOR PREVENTING HEART DISEASE [e.g. HEART ATTACKS] [ primary prevention of coronary artery disease ] DR S. SAHAI MD [Med.], DM [Card]
To.
The United States & Heart Disease Presented today by; Matt Lorup, Keith Arline, & Nick Knight.
Chronic Disease in Missouri: Progress and Challenges Shumei Yun, MD, PhD Public Health Epidemiologist and Team Leader Chronic Disease and Nutritional Epidemiology.
Health Disparities in Cardiovascular Disease Paula A. Johnson, MD, MPH Chief, Division of Women’s Health; Executive Director, Connors Center for Women’s.
Tt HRB Centre for Health and Diet Research The burden of hypertension Ivan J Perry, Dept. of Epidemiology and Public Health, University College Cork. Institute.
Hypertension as a Public Health Risk
Child deaths: Causes and epidemiological dimensions Robert E. Black, M.D., M.P.H. Johns Hopkins Bloomberg School of Public Health.
Non-communicable diseases David Redfern
Cardiovascular mortality in Russia and other countries
20 Cardiovascular Disease and Physical Activity chapter.
Caribbean Commission on Health & Development FOLLOW UP REPORT OF THE CARIBBEAN COMMISSION ON HEALTH AND DEVELOPMENT Presented to the 27 th Meeting of the.
CVD preventive interventions WORKSHOP Jurate Klumbiene Kaunas University of Medicine, Kaunas, Lithuania.
Combating disease and improving health Presented by ROSANNA AGBLE at Taking Action for the World’s Poor and Hungry People Beijing, China October 17–19,
William B. Kannel, MD, FACC Former Director, Framingham Heart Study
AN ASSESSMENT OF THE PRIMARY PREVENTION CONTROL PROGRAM OF PHC PREVENTIVE CARDIOLOGY CLINIC AMONG PATIENTS AT RISK FOR CVD: A Retrospective Cohort Study.
HYPERTENSION BURDEN AND CVD RISK PREDICTION IN AFRICA.
Hypertension the Community - Overview HYPERTENSION IN THE COMMUNITY: OVERVIEW.
Reducing Risk of Heart Disease & Stroke - A Life Long Quest Jeffrey P. Gold, M.D. University of Toledo Medical Center.
Epidemiology of CVD in the Elderly Karen P. Alexander MD Duke University Medical Center Duke Clinical Research Institute Disclosures: (1) Minor Research:
Modern Management of Cholesterol in the High-Risk Patient.
Non-Communicable Diseases Control Program _________________________________ K R Thankappan MD, MPH Additional Professor and Head Achutha Menon Centre.
CARDIOVASCULAR DISEASE (CVD)
Studying mortality trends: The IMPACT CHD Policy Model
1 Cardiovascular Disease in Asia. WHO CVD Atlas WHO Stroke Atlas The Burden of CVD in Asia: Stroke Deaths by Country,
The Renin-Angiotensin- Aldosterone System: Linking New Data and Mechanisms for Cardiovascular Risk Reduction VBWG.
AA-2-1 Jerome D. Cohen, MD, FACC, FACP Professor of Internal Medicine / Cardiology Director, Preventive Cardiology Programs St. Louis University Health.
Gerald S. Bloomfield, MD, MPH DGHI, Division of Cardiology, Duke University September 2013 Non-Communicable Diseases in LMICs: Myths, Facts and Opportunities.
Risk Factors for Coronary Heart Disease.. Did you know that…. In the UK, someone has a heart attack every 2 minutes, that’s 260,000 people per year. In.
7 April 2013 WORLD HEALTH DAY. World Health Day 2 On 7 April 1948, the World Health Organization (WHO) was created. Since then, WHO named April 7 as World.
Definition of the ‘health transition’ Trends of disease patterns in populations The 4 stages of the epidemiological transition The cardiovascular disease.
Can lifestyle moderate the burden of CVD? Evangelos Polychronopoulos, MD, MPH, PhD Asst Professor of Preventive Medicine Harokopio University.
Global burden of Cardiovascular Diseases
Health Statistics and Informatics Non-communicable diseases A global overview.
2007 Hypertension as a Public Health Risk January, 2007.
Meeting the Challenge of Non-Communicable Diseases Lecture 14.
Chapter 14 Patterns in Health and Disease: Epidemiology and Physiology EXERCISE PHYSIOLOGY Theory and Application to Fitness and Performance, 6th edition.
The Disease Control Priorities Project ( and Chronic Disease Presentation to the Hemispheric Meeting of the Social Protection.
The Burden of Chronic Diseases in the Developing World Stephen J. Spann, M.D., M.B.A. Professor and Chairman Department of Family and Community Medicine.
Global health in the news h/study-shows-spread-of-cigarettes-in- china.html?ref=health&_r=0.
Is different the prevalence of cardiovascular risk factors in the different economic levels ?
Over Time Additional Risk Factors Can Progress: Effect of Cholesterol and BP on CHD Risk in MRFIT Trial
FIGURE 1-2 CARDIOVASCULAR DISEASE DEATHS AS A PERCENTAGE OF ALL DEATHS IN EACH REGION AND TOTAL REGIONAL POPULATION, (DATA FROM MATHERS CD, LOPEZ.
World Health Organization
Outlines towards National NCDs Prevention and Control Strategy
DR GHULAM NABI KAZI WHO Country Office Pakistan
Epidemiology, Burden and Primary Prevention of Cardiovascular Disease Dr Shanthi Mendis MBBS MD FRCP FACC Coordinator Chronic Disease Prevention.
Noncommunicable Diseases: An Overview
Cardio- vascular diseases
Hypertension Hanna K. Al-Makhamreh, MD FACC Interventional Cardiology.
HDL cholesterol and cardiovascular risk Epidemiological evidence
Hypertension Update: How Low Shall We Go?
Prevention Cardiovascular disease
Heart Disease and Stroke Statistics — 2004 Update
Global burden of Cardiovascular Diseases
Cardiovascular Disease in Women Module III: Risk Assessment Tool
University College London
Presentation transcript:

Heavy Burden: Heavy Burden: Multiple Risk Factor Profile In Hypertension Patients Dong Zhao MD, PhD Department of Epidemiology Beijing Institute of Heart, Lung & Blood Vessel Diseases Beijing Anzhen Hospital

Free Template from Meaningful Numbers for Meaningful Numbers for Low & Middle Income Countries ♦ ♦ 85% world population; ♦ ♦ More than 80% of the global CVD deaths ; ♦ 420 million hypertension( 160 millions in China); ♦ 420 million hypertension( 160 millions in China); ♦ CHD will increase by 120% for women and 137% for men between 1990 to 2020; men between 1990 to 2020; ♦ Stroke will increase by 94% for women and 82% for ♦ Stroke will increase by 94% for women and 82% for men between 2000 to men between 2000 to 2020.

危险因素对疾病死亡率的影响 * Percentage of Mortality Attributable to Risk Factors *Based on The World Health Report Yach et al. JAMA. 2004;291: Developing countries Developed countries Blood pressure Tobacco Underweight Alcohol Cholesterol Unsafe sex Overweight Unsafe water, sanitation, hygiene Low fruit and vegetable intake Indoor smoke from solid fuels Physical inactivity

高血压患者中其他危险因素的患病率 Sedentary lifestyle Echo LVH Hyperinsulinemia Diabetes mellitus Obesity (BMI >30) HDL-C <1.0 mmol/L (<40 mg/dL) TC >6.2 mmol/L (>240 mg/dL) Cigarette smoking LVH=left ventricular hypertrophy; HDL-C=high-density lipoprotein cholesterol. Kaplan. Am J Cardiol. 1995;76: Prevalence (%) 50% 40% 40% 35% >30% >30% 25% 15%

未控制的高血压成年患者冠心病 和心血管危险因素的患病率 CRF=cardiovascular risk factors. Benner. ASH 20 th Annual Scientific Meeting. May 14-18, 2005; San Francisco, Calif. 

在男性高血压患者中心血管风险随其他 心血管危险因素的增多而升高 Systolic BP Cholesterol Systolic BP Cholesterol HDL-C Systolic BP Cholesterol HDL-C Diabetes Systolic BP Cholesterol HDL-C Diabetes Smoking Systolic BP Cholesterol HDL-C Diabetes Smoking ECG-LVH A combination of high BP and high serum cholesterol increases the risk of CHD, especially in men Adapted from Kannel. Am J Hypertens. 2000;13:3S-10S. 10-Year % Probability of Event

胆固醇水平与不同单一危险因素组合时 CVD 发病的 10 年绝对危险的比较 中国 CMCS TC  5.7 mmol/L (  220 mg/dL) 的患者 %

胆固醇与收缩压对 CHD 死亡危险的协同作用 Neaton JD, et al. Arch Intern Med. 1992;152: < Cholesterol quintile (mg/dL) SBP quintile (mm Hg) < Deaths /10,000 patient-years N=316,099

高血压伴发其他危险因素时增加心肌梗死的危险 Odds Ratio (95% CI) Smk (1) DM (2) HTN (3) ApoB/A1 (4) (1) All 4+Obes+PSAll RFs 2.9 ( ) 2.4 ( ) 1.9 ( ) 3.3 ( ) 13.0 ( ) 42.3 ( ) 68.5 ( ) ( ) ( ) Smk=smoking; DM=diabetes mellitus; Obes=abdominal obesity; PS=psychosocial; RF=risk factor; MI=myocardial infarction. Yusuf. Lancet. 2004; 364:

中国 岁人群 2 种心血管病危险因素的组合构成 1= 高血压 2= 血脂异常 3= 糖代谢异常 4= 肥胖 5= 吸烟 28% 17% 16% 10% 8% 6%5% 4% 2% 血脂异常 + 吸烟 高血压 + 血脂异常 高血压 + 吸烟

中国 岁人群 3 种心血管病危险因素的组合构成 1= 高血压 2= 血脂异常 3= 糖代谢异常 4= 肥胖 5= 吸烟 23% 21% 11% 10% 9% 6% 5% 4% 2% 高血压 + 血脂异常 + 吸烟 高血压 + 血脂异常 + 肥胖 高血压 + 血脂异常 + 糖代谢异常

The Treatment Rates of Hypertension in Selected Countries China: 28% India: 18% Turkey:17% Czech: 32% Egypt: 9% Mexico:<10 % Adapted from the numbers on Hypertension :886, Arch Inst Cardiol Mex :267 Health Soc Care Community :394, J Hypertension :1479 Hypertension :920, BMC Public Health ;1 Am J Hypertension :746 Blood Press :80, Hypertension :827 , WHO MONICA Project. (Using total hypertensive patients as denominators) USA:41 % Canada:24 % German:58 % UK:32 % AUS:51%

Hypertension Lipids( LDL,TG,HDL ) Diabetes Atrial Fibrillation Obesity Unhealthy life style CAD Stroke Barriers to Treatments for CVD Risk Factors or CVDs Few countries have guidelines based on their own data. Huge and still increasing absolute numbers of people with CVD risk factors or CVDs. Limited resources & Low expenditure on health Double burdens from CD and NCD Low capacity of CVD prevention & treatment. Unbalanced developments of high Tech. & high cost treatments and low cost treatments.

Huge absolute numbers of people with CVDs or risk factors in China Hypertension:* 160 millions Dyslipidemia: * 160 millions Diabetes:* 50 millions AMI (hospitalized)/year 0.8 million New stroke events/year millions *

Increasing Numbers of Hypertension Increasing Numbers of Hypertension Patients in China from 1958 to 2004 Patients in China from 1958 to

Projected increase in the population aged Projected increase in the population aged 65 and over from 2000 to 2040 in more-, 65 and over from 2000 to 2040 in more-, less- and least-developed countries less- and least-developed countries (Million) (Million) United Nations Population Division( hppt://esa.un.org/unpp

Hypertension Lipids( LDL,TG,HDL ) Diabetes Atrial Fibrillation Obesity Unhealthy life style CAD Stroke Barriers to Treatments for CVD Risk Factors or CVDs Few countries have guidelines based on their own data. Huge and still increasing absolute numbers of people with CVD risk factors or CVDs. Limited resources & Low expenditure on health Double burdens from CD and NCD Low capacity of CVD prevention & treatment. Unbalanced developments of high Tech. & high cost treatments and low cost treatments.

The comparison of per capita total The comparison of per capita total expenditure on health between high income expenditure on health between high income countries and low & middle income countries Adapted from WHO World Health Report 2002 Low & Middle income countries High income countries Low & Middle income countries High income countries N=146 N=39 N=146 N=39 $ 1547

Essential cardiovascular diseases drugs Essential cardiovascular diseases drugs in developing countries in developing countries (%) Asia, Africa Caribbean (19) Latin America (19) Latin America Middle Eastern Middle Eastern Crescent(10) Crescent(10) Chokalingam & Balaguer-Vintro WHF White Book 1999 Eastern, Central Europe (18) All regions (47) (47)

Hypertension Lipids( LDL,TG,HDL ) Diabetes Atrial Fibrillation Obesity Unhealthy life style CAD Stroke Barriers to Treatments for CVD Risk Factors or CVDs Few countries have guidelines based on their own data. Huge and still increasing absolute numbers of people with CVD risk factors or CVDs. Limited resources & Low expenditure on health Double burdens from CD and NCD Low capacity of CVD prevention & treatment. Unbalanced developments of high Tech. & high cost treatments and low cost treatments.

Percentages of Developing Countries Percentages of Developing Countries Lack of National Actions on CVD Prevention (%) Not govern- Not govern- ment priority ment priority Chokalingam & Balaguer-Vintro WHF White Book 1999 No tobacco No tobacco Sale legislation No national Program of CVD prevention No national Program of hypertension No national Program of diabetes No national Program for children No national Program for women

The Increasing Numbers of Cigarette Sale in China Million 32.6 Million 33.7Million (Box)

The comparison of mean out-of-pocket expenditure % The comparison of mean out-of-pocket expenditure % of total expenditure on health between high of total expenditure on health between high income countries and low & middle income countries income countries and low & middle income countries Adapted from WHO World Health Report 2002 Low & Middle income countries High income countries Low & Middle income countries High income countries N=146 N=39 N=146 N=39

Educational Level of Physicians in Primary and Secondary Hospitals in Beijing Educational Level of Physicians in Primary and Secondary Hospitals in Beijing Primary Hospital Primary Hospital Secondary Hospital Secondary Hospital University 24% Colleges 40% Technique school 36% University 70% Colleges 19% Technique school 11% WH Wang, D Zhao Chinese J Epidemiology 2004

Hypertension Lipids( LDL,TG,HDL ) Diabetes Atrial Fibrillation Obesity Unhealthy life style CAD Stroke Barriers to Treatments for CVD Risk Factors or CVDs Few countries have guidelines based on their own data. Huge and still increasing absolute numbers of people with CVD risk factors or CVDs. Limited resources & Low expenditure on health Double burdens from CD and NCD Low capacity of CVD prevention & treatment. Unbalanced developments of high Tech. & high cost treatments and low cost treatments.

Components in CVD Prevention and Control Diets Tobacco alcohol Exercise Health Environments CAD Blood Pressure Hypertension Lipids Dyslipidemia Glucose Diabetes Weight Obesity Stroke Peripheral arterials diseases Death Disability Upstream Midstream Downstream Prevention Treatment Major cardiac procedures In China (case numbers) Up to2002 PTCA CABG Coronary Stenting Awareness, treatment & control rate of hypertension In China(2001) DF Gu et al. Tsung O. Cheng. Hypertension :920 Inter. J Cardiology :425

Hypertension Lipids( LDL,TG,HDL ) Diabetes Atrial Fibrillation Obesity Unhealthy life style CAD Stroke Barriers to Treatments for CVD Risk Factors or CVDs Few countries have guidelines based on their own data. Huge and still increasing absolute numbers of people with CVD risk factors or CVDs. Limited resources & Low expenditure on health Double burdens from CD and NCD Low capacity of CVD prevention & treatment. Unbalanced developments of high Tech. & high cost treatments and low cost treatments.

Percentage of death from communicable diseases, Percentage of death from communicable diseases, maternal and perinatal and nutritional deficiencies in maternal and perinatal and nutritional deficiencies in total death in low income countries total death in low income countries ( about 48% population in developing countries) ( about 48% population in developing countries) (%) Africa Eastern Mediterranean SE Asia The Americas Africa Eastern Mediterranean SE Asia The Americas Adapted from WHO World Health Report 2002

Hypertension Lipids( LDL,TG,HDL ) Diabetes Atrial Fibrillation Obesity Unhealthy life style CAD Stroke Barriers to Treatments for CVD Risk Factors or CVDs Few countries have guidelines based on their own data. Huge and still increasing absolute numbers of people with CVD risk factors or CVDs. Limited resources & Low expenditure on health Double burdens from CD and NCD Low capacity of CVD prevention & treatment. Unbalanced developments of high Tech. & high cost treatments and low cost treatments.

Percentages of the Developing Countries Percentages of the Developing Countries without Guidelines for CVDs Treatment without Guidelines for CVDs Treatment (%) Hypertension Lipid Diabetes AMI Stroke Heart Failure Hypertension Lipid Diabetes AMI Stroke Heart Failure Chokalingam & Balaguer-Vintro WHF White Book 1999

Hypertension Lipids( LDL,TG,HDL ) Diabetes Atrial Fibrillation Obesity Unhealthy life style CAD Stroke Barriers to Treatments for CVD Risk Factors or CVDs Few countries have guidelines based on their own data. Huge and still increasing absolute numbers for people with CVD risk factors or CVDs. Limited resources & Low expenditure on health Double burdens from CD and NCD Low capacity of CVD prevention & treatment. Unbalanced developments in high Tech. & high cost treatments and low cost treatments.

Components in CVD Prevention and Control Diets Tobacco alcohol Exercise Health Environments CAD Blood Pressure Hypertension Lipids Dyslipidemia Glucose Diabetes Weight Obesity Stroke Peripheral arterial diseases Death Disability Upstream Midstream Downstream Prevention Treatment Main Target Upstream determinants for CVD prevention in low & middle income countries. Smoking Health Diets Exercises Alcohol

Free Template from Thank you for your attention.